MOGN Mgi Pharma (MM)

MGI PHARMA, INC. (Nasdaq:MOGN) today announced that its third quarter 2005 financial results conference call will be webcast live on Wednesday, October 19, 2005 at 5:00 p.m. ET. Lonnie Moulder, president and chief executive officer of MGI PHARMA, and other members of the Company's executive management team will review financial results, provide commentary on MGI PHARMA's business outlook, and answer questions from analysts and investors. All interested parties are welcome to listen to this audio webcast. MGI PHARMA will issue its third quarter 2005 financial results news release after the market closes on Wednesday, October 19, 2005. -0- *T What: MGI PHARMA's Third Quarter 2005 Financial Results Conference Call Webcast When: Wednesday, October 19, 2005 at 5:00 p.m. ET How: Live over the Internet - simply log on to www.mgipharma.com. In addition to the live webcast, the conference will be archived on the Company's web site for one week. *T About MGI PHARMA MGI PHARMA, INC. is an oncology and acute care focused biopharmaceutical company that acquires, researches, develops, and commercializes proprietary products that address the unmet needs of cancer patients. MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) injection and Gliadel(R) wafer (polifeprosan 20 with carmustine implant) in the United States. The company directly markets its products in the U.S. and collaborates with partners to reach international markets. For more information about MGI PHARMA, please visit www.mgipharma.com.